PRO MEDICUS LIMITED — Director's Dealing 2017

Nov 13, 2017

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Name of entity: Pro Medicus Limited ABN: 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Roderick Lyle
Date of last notice	23 November 2016
Date that director ceased to be director	14 November 2017

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Number & class of securities

200,000 ordinary shares held under Roderick Lyle

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of securities Note: Provide details of the circumstances giving rise to the relevant interest 140,000 ordinary shares Radling Pty Ltd: Trustee of the Lyle Superannuation Fund of which the Director is a Trustee and Member

• See chapter 19 for defined terms.

Appendix 3Z Page 1

30/9/2001

Appendix 3Z Final Director’s Interest Notice

Part 3 – Director’s interests in contracts

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
No. and class of securities to whichinterest relates	N/A

• See chapter 19 for defined terms.

Appendix 3Z Page 2

30/9/2001